Clinical Trial Detail

NCT ID NCT01848067
Title Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Thomas Jefferson University
Indications

prostate adenocarcinoma

Therapies

Abiraterone

Prednisone

Alisertib

Age Groups: adult

No variant requirements are available.